Theragen Inc. launched a personal genome typing service similar to 23andme's. However, the product was withheld due to legal issues.
From Biolecture.org
Revision as of 03:57, 22 March 2010 by imported>J
In Korea, there is a strict law preventing companies to perform non-diagnostic genetic experiment and analysis to make profit.
